High Incidence of Discontinuations Due to Adverse Events in Patients Treated with Ceftaroline-Reference-Cited by-同舟云学术

High Incidence of Discontinuations Due to Adverse Events in Patients Treated with Ceftaroline

Published:2014-05-07 Issue:7 Volume:34 Page:758-763
ISSN:0277-0008
Container-title:Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy
language:en
Short-container-title:Pharmacotherapy

Author:

Jain Rupali¹²,Chan Jeannie D.²³,Rogers Lisa¹,Dellit Timothy H.⁴⁵,Lynch John B.⁴⁵,Pottinger Paul S.⁵⁶

Affiliation:

1. Department of Pharmacy; University of Washington Medical Center; Seattle Washington

2. School of Pharmacy; University of Washington; Seattle Washington

3. Department of Pharmacy; Harborview Medical Center; Seattle Washington

4. Department of Medicine; Division of Allergy and Infectious Diseases; Harborview Medical Center; Seattle Washington

5. School of Medicine; University of Washington; Seattle Washington

6. Department of Medicine; Division of Allergy and Infectious Diseases; University of Washington Medical Center; Seattle Washington

Publisher

Wiley

Subject

Pharmacology (medical)

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/phar.1435/fullpdf

Reference18 articles.

1. Integrated analysis of FOCUS 1 and FOCUS 2: randomized, double-blinded, multicenter phase 3 trials of efficacy and safety of ceftaroline fosamil versus ceftriaxone in patients with community acquired pneumonia;File;Clin Infect Dis,2010

2. Integrated analysis of CANVAS 1 and 2: phase 3, multicenter, randomized, double-blind studies to evaluate the safety and efficacy of ceftaroline versus vancomycin plus aztreonam in complicated skin and skin-structure infection;Corey;Clin Infect Dis,2010

3. Integrated safety summary of FOCUS 1 and FOCUS 2 trials: Phase III randomized, double-blind studies evaluating ceftaroline fosamil for the treatment of patients with community-acquired pneumonia;Rank;J Antimicrob Chemother,2011

4. Addition of ceftaroline to daptomycin after emergence of daptomycin-nonsusceptible Staphylococcus aureus during therapy improves antibacterial activity;Rose;Antimicrob Agents Chemother,2012

5. Methicllin-resistant Staphylococcus aureus bacteraemia and endocarditis treated with ceftaroline salvage therapy;Ho;J Antimicrob Chemother,2012

Cited by 41 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. In vitro identification of underutilized β-lactam combinations against methicillin-resistant Staphylococcus aureus bacteremia isolates;Microbiology Spectrum;2024-08-06

2. Contemporary pharmacologic treatments of MRSA for hospitalized adults: rationale for vancomycin versus non-vancomycin therapies as first line agents;Expert Review of Anti-infective Therapy;2023-11-02

3. A Case of Ceftaroline-Associated Thrombocytopenia;Cureus;2023-10-24

4. An Update on Treatment Options for Methicillin-Resistant Staphylococcus aureus (MRSA) Bacteremia: A Systematic Review;Cureus;2022-11-14

5. A Review of β-Lactam–Associated Neutropenia and Implications for Cross-reactivity;Annals of Pharmacotherapy;2020-11-20